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Research Repott 
Chronic Dermal Ulcer Healing Enhanced with 
Monophasic Pulsed Electrical Stimulation 
-
The purposes of this randomized, double-blind, multicenter study were to com-
pare healing of chronic dennal uicen· treated with pulred electrical stimulation 
with healing of similar wounds treated with sham electrical stimulation and to 
evaluate patient tolerance to the therapeutic protocol. Pony-seven patients, aged 
29 to 91 years, with 50 Stt@! !1, //J, and N ulctm were randomly assigned to ei-
ther a treatment group (n=26) or a control (sham treatment) group (n=24). 
Treated wounds received 30 minutes of pulsed cathodal electrical stimulation 
twice daily at a pulse frequency of 128 pulses per second (pps) and a peak ampli-
tude of 29.2 mA if the wound contained necrotic tissue or any drainage that was 
not serosanguinous. A saline-moistened nontreatment electrode was applied 30.5 
em (12 in) cephalad from the wound. This protocol was continued for 3 days 
after the wound was debrided or exhibited serosanguinous drainage. Thereafter, 
the polarity of the treatment electrode on the wound was changed every 3 days 
until the wound progressed to a stt@! II classification. The pulse frequency was 
then reduced to 64 pps, and the treatment electrode polarity was changed daily 
until the wound was healed. Patients in the wntrol group were treated with the 
same protocol, except they received sham electrical stimulation. After 4 weeks, 
wounds in the treatment and control groups were 44% and 67% of their initial 
size, respectively. The healing rates per week for the treatment and control groups 
were 14% and 8.25%, respectively. The results of this study indicate that pulsed 
electrical stimulation has a beneficial effect on healing stage 11, Ill, and N 
chronic dennal ulcer.;. {Feedar ]A, Kloth LC, Gentzkow GD. Chronic dermal ulcer 
healing enhanced with monophasic pulsed electrical stimulation. Pbys Ther. 
1991;71639-649} 
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Since the mid-1900s, therapeutic 
doses of electrical current have been 
shown to augment healing of chronic 
wounds in human subjects and in-
duced wounds in animal models. 1...s 
Studies of cell cultures have shown 
that electrical fields can influence the 
migratory, proliferative, and functional 
capacity of cells involved in the heal· 
ing processY-14 Other studies have 
rep:med measurements of injury 
potentials, skin battery voltages, and 
wound lateral voltage gradients that 
have been theorized to trigger bio-
electrical repair and enhancement of 
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wound healing. 15,J6 If electrical signals 
play a role in the stimulation of 
wound repair, then exogenous appli-
cation of electrical current to chronic 
wounds could be expected to mimic 
the body's bioelectrical currents and 
enhance tissue healing processes. Re-
pons from numerous clinical and ex-
perimental studies provide evidence 
in support of this idea.l-14 
Since 1969, a number of publications 
reJated to the clinical use of electrical 
stimulation for treatment of chronic 
dermaJ ulcers have reported acceler-
ated rates of heaJing of 13% to 46% 
per week during an average of 6.6 
weeks compared with small numbers 
of control wounds that healed be-
tween 5% and 15% per week.l-4 In all 
of these studies, the polarity of the 
wound cledrode was changed period-
ically during the study period. Two of 
these studies reported using either 4 
hours3 or 45 minutes4 of electrical 
stimulation treatment per day, 5 days 
per week; the other two studies re-
jX)rted using 6 hours of stimulation 
per day, 7 days per week.1,2 All of 
these studies delivered 200 to 1,000 
IJ.A of either direct currentl-3 or time-
avernged pulsed current" to the 
wound tissues. 
Additional support for using direct 
current or time-averaged pulsed cur-
rent electrical stimulation to acceler-
ate healing of chronic dermal ulcers 
is provided by the results of numer-
ous animal studies. Although there is 
lack of agreement on the effects of 
polarity, many of these studies have 
reported that electrical stimulation 
from direct current'>-7 and time-
averaged pulsed current devicess pro-
duces faster closure'HI and greater 
tensile strength of the scar tissue in 
acute induced wounds than in control 
wound<>. Other experimentaJ animal 
studies1s-Is have confirmed that weak 
cathoda1 electrical stimulation solubi-
lizes clotted blcxx:l, which provides 
support for the clinical observation 
that cathodal direct current stimula-
tion facilitates debridement of ne-
crotic wound tissue consisting primar-
ily of coalesced blood elements. 
Recently, studies on induced wounds 
in pigs have reported that electrical 
stimulation can improve the survival 
of skin flaps 19 and significantly in-
crease the rate of wound epithelializa-
tion' and contraction20·2 1 and the pro-
liferation of fibroblasts.2o 
Some of these findings are in turn 
supported by in vitro studies in 
which isolated epidermal cells, cell 
clusters, and cell sheets demon-
strated galvanotaxis in migrating 
toward the cathodeY-10 A galvano-
taxic effect on other cells involved 
in the tissue-healing process has 
been demonstrated in a number of 
other studies as well. Macrophages 
have been shown to migrate toward 
the anode, 11 whereas neutrophils 
have been observed to migrate 
toward both the anode and the cath-
ode.n.n Monguio 12 and Dineur, 14 
however, have reported that neutro-
philic leukocytes migrate toward the 
cathode in regions in which infec-
tion or inflammation are present, 
and Eberhardt et al22 have found 
that electrical stimulation increases 
the relative number of neutrophilic 
leukocytes in human skin exudate. 
Weiss et aJ23 have indicated that, 
following exposure to exogenous 
current, there is evidence of a re-
duction in human tissue mast cells. 
Such cells are present in increased 
numbers in a variety of fibrotic dis-
orders including keloids.23 Weiss 
and colleagues speculate that the 
effect of electrical stimulation on 
scar formation may be due to a de-
crease in mast cell migration. 
That cell functionaJ capacity may be 
influenced by changes in potential is 
supported by cell culture studies in 
which erythrocytes and fibroblasts 
were exposed to electrical currents. 
Harrington and Becker24 have shown 
that frog erythrocytes subjected to 
electrical current synthesize ribonu-
cleic acid and protein, whereas eryth-
rocytes not exposed to current do not 
produce appreciable amounts of mac-
romolecules. In view of the significant 
differences between human and frog 
erythrocytes, this effect may not relate 
to the clinical use of electrical stimu-
lation. Bassett and Hernnann25 ex-
posed Green's 3T-6 fibroblasts in cul-
ture to continuous direct current and 
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demonstrated increases in deoxyriOO-
nucleic acid (DNA) production and 
collagen synthesis after 14 days. By 
interrupting the direct current, they 
found that DNA production increased 
20% and that collagen synthesis in-
creased 100%. 
Bourguignon and Bourguignon26 re-
ported that high voltage pulsed cur-
rent stimulation of normal human 
fibroblasts in culture led to increased 
DNA production and protein synthe-
sis. Maximum synthesis was noted to 
occur in cells lying in close proximity 
to the cathcxle. This observation is 
consistent with previous evidence 
linking a proliferative response to 
electronegativity. 
Growth factors play an important role 
in wound healing, and the trnnsforma-
tion of growth factor-~ has a funda-
mental role in collagen synthesis. Fa-
langa et a1~ have demonstrated that 
dermal fibroblasts in culture, stimu-
lated with pulsed current at 100 
pulses per second (pps) and 100 V, 
had increases in the expression of 
receptors for transforming growth 
factor-~ that were six times greater 
than those of control fibroblasts. 
The effects of exogenous currents on 
wound tissues and cells may enhance 
the effeLts of the "skin battery," which 
is believed to reside within the epi-
dermis and to augment wound heal-
ing. Foulds and Barker2s have demon-
strated that a voltage is maintained 
across the epidermis. They report that 
the outer surface of skin is negatively 
charged with resped to the positively 
charged dermis. The average voltage 
measured on the surface of human 
skin is -23.4 m¥. 15 In wounded 
mammalian skin, wound currents 
have been shown to genernte lateral 
intraepidermal voltage gradients sur-
rounding the wound as a very narrow 
1-mm band.I6 At 0.25 mm from the 
wound edge, the amplitude of this 
voltage gradient falls off about three-
fold. 29 Interestingly, corresponding 
decreases in epidermal cell migration 
also occur a very short distance from 
the wound edge. 
64() /13 
The purposes of this clinical smdy 
were (1) to compare healing of 
chronic dennal ulcers treated with 
pulsed electrical stimulation with 
healing of similar wounds treated 
with sham elearical stimulation and 
(2) to evaluate patient tolerance to the 
therapeutic protocol We hypothe-
sized that chronic dermal ulcers 
treated with pulsed elearical current 
would heal faster and more com-
pletely than ulcers treated with sham 
electrical stimulation. 
Sub}octs 
Fifty-nine patients (67 wounds) at nine 
investigational sites participated in 
the study. Eight patients each had 2 
wounds, which were separately ran-
domized and entered into the study. 
Of the initial 59 patients, the data fOr 
12 patients (17 wounds) were not in-
cluded in the data analysis. Four 
wounds were excluded because the 
patients did not complete the 4-week 
study, 4 because the wound size did 
not meet entry criteria, 3 for uninter-
pretable measurements, and 6 because 
of omitted or incorrect treatments. The 
data for the remaining 47 patients (50 
wounds [26 in the treatment group, 
24 in the control group]) were thus 
available for the data analysis. 
Patiem ages ranged from 29 to 91 
years. The mean ages of the patients 
in the treatment and control groups 
were 66.6 (SD=15.6) and 60.7 (SD 
= 19.2) years, respectively. The pa-
tients (52% male, 48% female) were 
equally distributed between the treat-
ment and control groups (Tab. 1). 
The subjects in this study were pa-
tients with stage II, Ill, or N chronic 
dennal ulcers. There were no age or 
sex restrictions for participation in the 
study. The patients were participants 
in the study for 4 week<;, because we 
believed that some measurable effect 
on healing would occur in that 
amount of time. Patients were ex-
cluded from the study if they had car-
diac pacemakers, peripheral vascular 
disease disposing them to thrombosis, 
or active osteomyelitis or if they were 
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-Table 1. Palienl and Ulcer Characteristics 
Age {y) 
X 
so 
Range 
Sex(%) 
Male 
Female 
Stage 
II 
Ill 
IV 
Total 
Etiology 
Pressure sore 
Surgical 
vascular 
Traumatic 
Total 
Location 
Hlp/ISchium 
Sacrum/coccyx 
Leg 
Foot 
Othera 
Total 
Duration (%) 
<1 mo 
1-3 mo 
3-6 mo 
6--12 mo 
>12 mo 
~Head, back, axilla. 
Control Group 
(n=24) 
60.7 
19.2 
30-90 
50.0 
50.0 
2 
17 
s 
24 
18 
3 
2 
24 
6 
9 
6 
2 
24 
20.8 
16.7 
16.7 
25.0 
20 8 
pregnant or receiving long-term radia-
tion therapy, steroid therapy, or che-
motherapy. Following the initial eval-
uation to determine whether the 
wound and the patient met the selec-
tion criteria, each patient signed an 
infonned consent form. Patients were 
then randomly assigned to either an 
electrical stimulation treatment group 
or a control (sham electrical stimula-
tion) group. 
Treatment 
Group 
(n=26) 
66.6 
15.6 
29-91 
538 
46.2 
0 
22 
4 
26 
17 
6 
0 
3 
26 
8 
4 
5 
s 
4 
26 
23.1 
269 
7.7 
23.1 
19.2 
Wound Selection 
Total 
63.8 
17.5 
29--91 
52.0 
48.0 
2 
39 
9 
50 
35 
9 
5 
50 
14 
13 
6 
11 
6 
50 
22.0 
22.0 
12.0 
24.0 
20.0 
Wounds could be stage II, Ill, or N 
pressure sores; ulcers caused by vas-
cular insufficiency; or wound<; caused 
by trauma or surgery. The wound 
stages were defined as follows: stage 
II wounds=full-thickness skin defects 
extending into the subcutaneous tis-
sue; stage III wounds=defects extend-
ing into the muscle; and stage N 
wounds=defects extending into the 
bone or the joint.30 Wounds could be 
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Figure 1. Duration and amplitude charaden'stics of the monophasic pulsed cur-
rent at frequencies of64 and 128 pulses per second (pps). 
between 4 and 100 cm2 in size. 
Wounds excluded from the study 
were those with uninterpretable mea-
surements (ie, measuremems ob-
tained when investigators were incon-
sistent in how they measured the 
wound) and those that were com-
pletely occluded by eschar, those that 
were hemorrhaging, or those of can-
cerous etiology. 
Of the 50 wounds represented in the 
data analysis, 2 were stage II wounds, 
39 were stage III wounds, and 9 were 
stage N wounds (fab. 1). Both stage 
II wounds were in the control group. 
Table 1 also shows the etiology, loca-
tion, and duration of aJI ulcers. The 
etiologies of the wounds (35 pressure 
sore, 9 surgical, 1 vascular, and 5 trau-
matic) were approximately equivaJent 
in the two groups. The locations of 
the ulcers were hip/ischium (n=14), 
sacrum/coccyx (n=13), leg (n=6), 
foot (n= 11), and other (n=6), and 
these locations were approximately 
equally distributed in the two groups. 
Duration of the ulcer was also equiva-
lent in the groups (ie, 22%=<1 
month, 22%=1-3 months, 12%=3--6 
months, 24%=6---12 months, and 
20%=>1 year). Initial wound size 
was a mean of 14.64 cm2 in the treat-
ment group and 16.93 cm2 in the con-
trol group. There were more patients 
with tunnels or undermining in the 
treatment group than in the control 
group (26.9% versus 16.7%, rcspc"C-
tively). There were no significant dif-
ferences (P< 10) between the treat-
ment and control groups for any of 
the patient, ulcer, or wound care 
characteristics. TherefOre, the ran-
domization procedure appears to 
have successfully provided compara-
ble treatment and control groups. 
Instrumentation 
The electrical stimulation device used 
in this study was the Vara;PuJse® stim-
ulator,* which delivers monophasic 
pulsed current. (Note: the Vara!Pulse® 
stimulator is no longer commercially 
available.) A Tektronix model 2430 
digital oscilloscope t was used to pass 
0Staodym•mics Inc, 1225 Florida Ave. PO Box 1379, Lungmom, CO 80502·1379. 
trektroni>! Inc, p0 Box 500, Beavenon, OR 97077. 
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the output pulse through a 1-kf! load 
at 29.2 V (output dial set at 35). The 
output pulse was observed to have 
instantaneous rise and decay times of 
the waveform leading and trailing 
edges, resulting in a rectangular pulse 
with an amplitude of 29.2 rnA and a 
duration of 132 IJ.S. At this resistive 
load, the current per pulse delivered 
to the stainless steel, sponge-covered 
electrodes of the active stimulaton. 
was 3.9 11-C. For the purpose of this 
study, pulse frequencies of 128 and 
64 pps were used. At these frequen-
cies, the pulse period was determined 
to be 7.74 and 15.5 ms, respectively 
(Fig. 1). Thus, the accumulated pulse 
charge was 499.2 ,.,..c;s at the higher 
pulse frequency and 249.6 !J.C/s at the 
lower frequency. 
Procedure 
This study was conducted as a ran-
domized, double-blind clinical trial. 
First, a randomization list was estab-
lished for each center by the central 
study director. Each consecutive num-
bered patient at each center was then 
randomly assigned to either a treat-
ment group, which used an active 
stimulator, or a control group, which 
used a stimulator that had been modi-
fied to pnx:iuce no output current. 
The randomization procedure was 
controlled to ensure that equal num-
bers of patients were assigned to the 
treatment and control groups at each 
center. The clinical investigators did 
not have access tu the randomization 
lists and therefore did not know 
whether a particular device was active 
or inactive. Neither the investigators 
nor the patients were aware of which 
type of device was used for a particu-
lar wound during the 4-week study 
period. Patients in the treatment and 
control groups received identical 
treatments during the study period, 
except for the rype of stimulator (ie, 
active versus inactive) that was used. 
A few patients reported a tingling sen-
sation; however, this sensation was 
reponed by patients in both groups, 
and we do not believe that it comprO-
mised the blinding procedure. All 
investigators agreed to comply with 
the blinding procedure, and monitor-
642!15 
-Table 2. Summary of Wound Length-Width Products for Pallents in 1::/ectrical St(mu/ation Treatment Group (n=26r 
Wound 
No. 
TR-01 
TR..02 
TR-03 
TA-04 
TR-05 
TA-06 
TR-07 
TR-08 
TR-09 
TR-10 
TR-11 
TR-12 
TR-13 
TR-14 
TA-15 
TA-16 
TR-17 
TR-18 
TR-19 
TR-20 
TR-21 
TR-22 
TR-23 
TR-24 
TR-25 
TR-26 
X 
SD 
N 
lniUal Wound Size 
(om') 
5.00 
15.64 
21.50 
44.00 
864 
600 
35.38 
7.00 
585 
9.89 
4.00 
4.60 
12.50 
4.80 
40.50 
5.44 
16.25 
4.95 
800 
9.00 
22.80 
21.00 
18 45 
17.39 
28.00 
4.20 
14.65 
11.37 
26 
Percentage of lniUal Length-Width Product 
Week 1 Waek2 Week3 
75.00 75.00 75.00 
62.66 35.17 21.74 
87.72 88.88 102.00 
93.81 75.00 54.09 
100.00 81.48 41.67 
33.33 30.00 8.33 
62.41 21.20 1767 
85.00 91.14 87.43 
76.92 85.47 51 28 
84.52 54.60 17.69 
5850 2800 31.50 
66.52 33.91 45.65 
100.00 68.00 57.60 
76.67 5417 31.25 
95.56 90.25 92.37 
94.12 77.21 82.72 
59.08 40.62 15.88 
75.76 24.24 45.45 
78.75 80.00 75.00 
75.00 35.56 31.11 
88.33 105.61 154 61 
100.00 77.38 74.57 
95.39 82.38 65.04 
60.72 31.74 
125.00 125.00 100.00 
94.29 94.29 6857 
81.77 65.97 5692 
18.28 27.34 33.37 
25 26 26 
Total No. 
Week4 Last Week of Weeks 
72.00 12.00 15 
10.55 160 7 
92.09 70.70 14 
39.45 509 8 
6.94 2.78 5 
4.17 417 4 
1.41 006 10 
75.00 0.71 15 
68.38 68.38 4 
0.40 0.40 4 
21.00 250 7 
48.04 48.04 4 
70.56 12.00 14 
15.63 12.50 8 
6644 25.93 8 
62.13 62.13 4 
4.62 0.37 6 
34.14 34.14 4 
75.00 50.00 8 
18.33 18.33 4 
62.72 000 12 
49.71 35.00 14 
6640 57.13 5 
19.84 19.84 4 
87.50 0.00 15 
68.57 6857 4 
43.89 23.55 7.96 
29.47 24.95 4.13 
26 26 26 
"Note tnit.Jal wound size is given as length-width produG (tn square centimeters). Weekly measuremen~~ are gtvcn as the percentage of the initial 
wound size. 
ing did not reveal any evidence that 
this procedure had been compro-
mised. To funher ensure that the clin-
ical trials were blinded, the pen;ons 
who administered the treatment~ 
were different from those who ob-
tained the measurements. To ensure 
consistency of the measurement tech-
nique across clinical sites, a nurse 
specialist trained all of the personnel 
who obtained the measurements and 
monitored all clinical sites during the 
study by periodic site visitations. Fur-
thermore, the same person at each 
16/643 
clinical site took all of the measure-
ments on a given patient throughout 
the study. 
Each wound was assessed at the be-
ginning of the smdy before the active 
or sham stimulation protocol was be-
gun. A wound/patient clinical hi~tory, 
including wound etiology, prior treat-
ment received, and medications being 
taken, was recorded. Wound duration 
information was obtained by patient 
self-report when not available from 
patient records. 
Once a week, the wound appearance 
(eg, color, presence or absence of 
necrotic and/or granulation tissue) 
was documented, and length and 
width me<ll>uremems of the wound 
were recorded. A color photograph 
was taken every 2 weeks to provide a 
permanent record and for monitoring 
purposes. The length of the wound 
was recorded as the wound's largest 
diameter, and the width of the wound 
was recorded as the wound's largest 
diameter perpendicular to the length. 
This measurement technique is sim-
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-Table 3. Summary of Wound Length-Width Products for Patients in Sham Treatment Group (n=24)" 
Wound lnlllal Wound Size Percentage of Initial Length-Width Product 
No. (om') 
SH-{)1 6.00 
SH-Q2 4.50 
SH-03 12.25 
SH.Q4 5.25 
SH<l!i 7.50 
SH-06 12.25 
SH-07 3000 
SH-08 12.25 
SH-09 6.40 
SH-10 74.70 
SH-11 67.50 
SH-12 8.40 
SH-13 5.10 
SH-14 5.55 
SH-15 20.40 
SH-16 40.00 
SH-17 5.28 
SH-18 4.05 
SH-19 6.76 
SH-20 41.48 
SH-21 6.21 
SH-22 10.50 
SH-23 4.00 
SH-24 10.00 
x 16.93 
SD 1979 
N 24 
Week 1 
83.33 
66.67 
166.67 
90.00 
96.65 
100.00 
143.92 
61.25 
94.65 
88.15 
95.24 
100.00 
78.75 
87.12 
98.77 
99.41 
87.22 
69.57 
100.00 
110.00 
100.00 
9606 
23.51 
21 
Woek2 
62.50 
38.89 
45.71 
178.67 
66.67 
100_00 
14000 
153.96 
26.56 
96.72 
57.04 
72.38 
117.65 
97.30 
80.88 
60.00 
79 55 
72.59 
107.84 
85.34 
69.57 
95.24 
9000 
86.74 
36.09 
23 
Waek3 WHk4 
84.00 9000 
21 78 778 
5.31 
178 67 178.57 
50.00 21.33 
as 11 8359 
110.00 108.33 
130.29 139.59 
3.28 0.00 
78.98 81.39 
38.30 6.40 
5357 29.76 
29.41 37.65 
9081 100.90 
81.57 66.18 
64.12 28.13 
57.95 51.52 
5778 6568 
107.84 142.01 
8088 90.89 
63.77 57.97 
76.19 81.71 
45.00 38.50 
90.00 99.00 
73.04 67.18 
37.54 47.32 
23 24 
~Note: Inilial wound size is given as length-width product (in square centimeter;). 
wound size. 
Weekly measurements are given as the percentage of the in mal 
pie, reproducible, and easy to accom-
plish at the bedside. In addition, eval-
uators were required to illustrate the 
position of these measurements on a 
wound diagram. Thus, the primary 
measure of wound healing used in 
the study was the measurement of 
wound size. 
The protocol consisted of two 30-
minute active or sham electrical stim-
ulation sessions, given 7 days a week 
The protocol was based on those 
used in previous clinical studiesl--4 
and consisted of the following steps: 
I. 
2. 
3. 
Irrigation of the wound bed with 
saline solution before each treat-
ment and maintenance of a saline-
moistened wound environment 
between treatments. 
Application of clean, saline-
moistened gauze sponges directly 
over stage II wounds or into stage 
III and IV wounds. 
Application of a 16-x 16-cm non-
treatment sponge electrode moist-
ened with tap water and secured to 
the skin a minimum of 30.5 em 
(12 in) from the wound site. 
Physical Therapy;Volume 71, Number 9/September 1991 
4. Application of a 7.5-X 7.5-cm treat-
ment sponge electrode on top of 
the saline-moistened gauze cover-
ing the wound and secured in 
place. 
5. Vara/Pulse® stimulation controls 
were set at a pulse frequency of 
128 pps and at an amplitude of 35 
mA, and the polarity switch was set 
to deliver a negative charge to the 
electrode placed on the wound. 
6. Using these stimulus variables, two 
30-minute treatments were given 
daily Cl days a week), with a mini-
644/17 
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Figure 2. Mean percentage of reduction in wound size with standard error for each 
of 4 weeks of treatment for the electrical stimulation group (~TIM) and the sham efectn'cal 
stimulation group (SffAM). 
mum of 4 hours and a maximum of 
8 hours between treatment sessions. 
7. In this study, only 10% of each 
group received surgical or whirl-
pool debridement. The wounds 
not requiring surgical or whirlpool 
debridement were treated with 
electrical stimulation or dressings 
(generally for about 7 days) until 
the wound spontaneously debrided 
or a serosanguinous drainage ap-
peared. In either case, negative 
polarity of the wound electrode 
was continued for 3 additional 
days. Thereafter, the polarity of the 
wound electrode was changed ev-
ery 3 days until the wound healed 
to a stage II classification. At that 
time, it was felt that an excessive 
charge delivered at 128 pps might 
overstimulate the wound tissue; 
therefore, the pulse frequency was 
decreased to 64 pps. In addition, 
the p.::>larity of the wound elec-
trode was alternated daily until the 
wound closed. On the average, 
{XIIarity of the wound electrode 
was changed six times in the 28-
day period. 
8. If a wound initially was a clean 
stage II wound, treatment was 
started as described in step 7. 
Patients residing in skilled nursing 
facilities were treated daily by a health 
care practitioner (ie, physical thera-
pist, registered nu~e. physician) who 
was a member of the study team for 
that facility. For outpatients who lived 
at home, either the patient or a family 
member was trained to apply the 
stimulator each day. Eight patients in 
each group received their treatment 
as outpatients. In all instances, health 
care practitioners obtained the wound 
measurements each week. Evaluators 
who measured the wounds were un-
aware as to whether the electrical 
stimulator was an active or an inactive 
device. 
Patients in the control group, after 
completing the 4-week trial, were 
then given the opportunity to switch 
to an active stimulator. Patients who 
chose to cross over to an active stimu-
lator were monitored and treated in 
the same manner as during the pre· 
ceding 4-week trial The patients who 
received active electrical stimulation 
were treated for at least 4 weeks or 
until wound closure occurred. All 
patients' wounds were assessed at 
weekly intervals for 4 weeks after the 
study protocol was terminated. 
Data Analysis 
Data from the treatment and control 
groups were statistically analyzed to 
determine comparability of the 
groups with regard to factors that 
might influence outcome. We ana-
lyzed the following characteristics: 
sex, age, wound stage, wound dura-
tion, wound etiology, wound location, 
presence of tunnels or undermining, 
presence of eschar, initial wound 
measurements (length, width, and 
length-width product), patient mobil-
ity status (bedridden, wheelchair user, 
ambulatory), previous and concurrent 
treatments of wound, systemic condi-
tions, concurrent treatment for other 
conditions, and inpatient versus out-
patient treatment. The statistical analy-
sis involved the use of the chi-square 
test (with the Yates continuity correc-
tion for fourfold tables) for discrete 
factors such as wound stage or loca-
tion and the two-sample t test for 
quantitative measures such as wound 
duration or initial size. 
Wound length and width were mea-
sured at weekly intervals during the 
treatment period. Because wound 
measurement values were obtained 
for both treatment and control groups 
each week for 4 weeks, we used the 
wound size data (defined as the 
length-width prcxiuct) at the 4-week 
point as the definitive data for com-
parison purposes. A reduction in the 
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Figure 3. Comparison of wound healing in electrical stlmuJation group (SFJM) 
and sham electrical stimulation group (SHAM) after 4 weeks of treatment. 
length-width product was considered 
an indication of wound hea1ing. 
These changes in wound size were 
assessed by expressing each wound's 
length-width product at each week as 
a percentage of its initial length-width 
prcxluct, allowing comparisons of all 
wounds, regardless of their absolute 
size. The means of the individual per-
centageS for each group's wounds 
were compared, using the two-sample 
t test (one-tailed) to evaluate the null 
hypothe~is of no treatment differ-
ences. For the patients in the control 
group who crossed over to active 
stimulati.on, a paired t test (one-railed) 
was used to compare the wound data 
obtained during the 4 weeks of active 
treatment with the wound data ob-
tained during the 4 weeks of sham 
treatment A stepwise multiple-
regression analysis was perfonned 
using the week-4 wound size as the 
dependent variable to evaluate the 
significance of treatment group in 
wound healing, while adjusting for 
other factors that might influence the 
outcome of wound healing. 
Results 
Tables 2 and 3 present summaries of 
the wound length-width products dur-
ing the course of the study for all 
wounds. The measurements for each 
week are expressed as a percentage 
of the initial wound size. After 4 
weeks, the 26 wounds in the treat-
ment group were 44% of their origi-
nal size, whereas the 24 wounds in 
the control group were 67% of their 
initial size (P<.02). These differences 
represent an average healing rate of 
14% per week for the treatment 
group versus 8.2"5% per week for the 
control group. r>;one of the treatment 
group's ulcers increased in size; 5 of 
the control group's ulcers increased 
in size. Figure 2 graphically demon-
strates the substantial difference in 
healing between the groups. 
Only two variables, presence of tun-
nels or undennining (P=.OOl) and 
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treatment group (P=.007), were 
found in the stepwise multiple-
regression analysis to be significantly 
(P<.05) associated with the week-4 
wound size. The fitted model from 
this analysis indicates that the ex-
pected percentage of initial wound 
size after 4 weeks would be 45.7% 
(plus 43.2% if tunnels or undennin-
ing were present; minus 28.7% if they 
received active stimulation). lhat is, 
wounds would heal significantly less 
well if tunnels or undermining were 
present and significantly better if they 
received active stimulation. As noted 
previously, more of the wounds in 
the treatment group than in the con-
trol group had tunnels or undennin-
ing, indicating that, if there was a bias 
attributable to differences within the 
treatment group, it was against the 
active treatment. 
For descriptive purposes only, we 
categorized the 4-week results accord-
ing to the following classification, 
which did not lend itself to statistical 
analysis: excellent results-wound 
less than 25% of its initial size or 
completely healed, good results--
wound between 25% and 75% of its 
initial size, and poor results-no 
change or wound greater than 75% of 
its initial size. Figure 3 shows that, at 
4 weeks, a substantially higher pro-
ponion of the treatment group's 
ulcers (92%) than of the control 
group's ulcers (54%) could be catego-
rized as good or excellent. 
Founeen of the wound<> in the control 
group were crossed over to nonran-
domized active electrical stimulation 
after the patients completed the 4 
weeks of sham treatment (Tab. 4). M-
ter 4 weeks of sham treatment, these 
14 wound<> were 88.7% of their initial 
size and had healed at a rate of 2.9% 
per week. After 4 weeks of active elec-
trical stimulation, these same wound<> 
were 49% of their size at the time of 
crossover and had healed at a rate of 
12.8% per week. The reduction in 
wound size was fourfold greater after 
receiving aaive stimulation (P=.OOS). 
These wounds continued to be treated 
for a mean total treaunent time of 10.8 
weeks; all wounds except 2 continued 
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-Table 4. Summary of Wound Length-Width Products For Patients Who Crossed Over from Sham to Active Stimulation (n= 14) 
Percentage of 
Initial Size After 4 Percentage of Wound Size Percentage of Wound Size at Total No. of Weeks 
Wound Weeks of Sham at Crossover After 4 Weeks Crossover After Last Week ot of Active 
No. Treabnent of Active Stimulation Active Stimulation Stimulation 
SH-01 90.00 66.66 37.03 10 
SH-04 178.67 32.00 6.40 15 
SH-06 83.59 26.37 000 7 
SH-07 108.33 79.26 61.54 10 
SH-08 139.59 98.25 85.96 7 
SH-12 29.76 10.00 0.00 5 
SH-13 37.65 36.46 47.40 8 
SH-15 66.18 74.07 13.63 11 
SH-16 28.13 17.78 0.00 10 
SH-18 65.68 7.89 000 7 
SH-19 142.01 52.50 0.00 13 
SH-20 90.89 93.10 89.66 11 
SH-22 81.71 76.92 79.25 16 
SH-24 99.00 15.15 0.00 12 
X 88.66'" 49.03 8 30.06 10.80 
so 42.16 30.83 34 53 3.07 
N 14 14 14 14 
"Wounds ~ignificantly smaller after a<-1ive stimulation thJn after sham treatment (P=.OO'i~ t teM, one-tailed). 
to improve, and 43% (6/14) healed 
completely. 
After the 4-week double-blind portion 
of the study, 17 of the actively treated 
wounds continued to be treated. After 
a mean of R weeks' total treaunent 
time, the wounds had healed to 
23.6% of their initial size, on average. 
In addition, 3RS% (10!26) had healed 
completely or nearly completely 
(>95% healed) and 61.5% (16!26) 
had healed more than 80%. The only 
treaunent-related adverse effects re-
ported were minor uncomfortable 
sensations in the wound (ie, tingling), 
which occurred in IS% of the patients 
(10% of the control group and 20% 
of the treatment group). 
Dlacuaalon 
The results of our study supported 
our hypothesis and are in accord wilh 
the results of olher studies1__., showing 
that electrical stimulation enhances 
the r:ate and extent of healing of 
20/647 
chronic wounds. Our findings are 
also in accord with those of investiga-
tions demonstrating that electrical 
stimulation can be used to promote 
healing of acute wounds induced in 
animals5·7 ·8,19---2 l and to prevent necro-
sis from developing in ischemic skin 
flaps in humans.31 
We found that, after 4 weeks of treat-
ment, wounds in the treatment group 
healed to a mean of 44% of their ini-
tial size at a mean healing r:ate of 14% 
a week. During the same period, 
wounds in the control group healed 
to a mean of 67% of their initial size 
at a mean healing r:ate of 8.25% a 
week. Our results suggest that Kloth 
and Feedar were correct when they 
stated that the electrical stimulation 
treatment time required to satisfacto-
rily enhance tissue healing does not 
need to exceed 60 minutes per day, 5 
to 7 days a week.4 This treatment time 
is in contrast to the 20 to 42 hours of 
elearical stimulation treatment per 
week reported in other studies. 1-3 We 
believe that treatment rimes between 
the 3.7 hours per week reponed by 
Kloth and Feedar4 and the 7 hours 
per week reported in this study may 
be beneficial. 
Further evidence supporting the use 
of pulsed electrical stimulation as 
an efficacious treatment of chronic 
wounds is provided by the 14 wounds 
in the control group of this study that 
were crossed over after 4 weeks to a 
nonr:andomized active electrical stim-
ulation treatment group. After 4 
weeks of treatment, these wounds 
healed at a mean rate of 12.8% a 
week to 49% of their pretreatment 
size. Kloth and Feedar reponed a sim-
ilar response by a small group of 
crossover wounds in a previous 
study.4 
That wounds in the control group 
healed to a mean of 67% of their ini-
tial size after 4 weeks is not surprising 
to us, because each of these wounds 
received an intensive amount of addi-
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tional care, including maintenance of 
a moist wound microenvironment as 
pan of the sham treatment Despite 
the improvement of the control 
group's wounds after 4 weeks, how-
ever, it b evident that the treatment 
group's wounds benefited not only 
from maintenance of a moist wound 
environment, but also from the elec-
trical stimulation. This treatment pro-
tocol very likely accounts for the fact 
that 56% of the treatment group's 
wound. demonstrated good healing 
during the 4-week double-blind study 
as compared with only 33% of the 
control group's wounds. 
We believe there is growing evidence 
that exogenous electrical currents can 
augment the healing process of der-
mal ulcers, perhaps by mimicking the 
txxly's ovm bioelectrical signals. We 
believe convincing evidence exists 
that electrically augmented healing of 
nonunion and delayed union fractures 
is best facilitated by invasive cathodal 
stimulation with between 5 and 20 ~ 
of direct current.32.33 K1oth and Fee-
dar-! used a monophasic pulsed-
current device to deliver ela:;trical 
stimulation at a frequency of 105 pps 
(342 j.LC/S) to wound tissue via the 
anode for 45 minutes daily, 5 days a 
week, and reponed complete healing 
of nine wounds in a treatment group 
in 7.3 weeks. In our study, we also 
used a monophasic pulsed-current 
device to initially deliver electrical 
stimulation at a frequency of 128 
pps (500 j.LC/s) via alternations of 
cathode and anode every 3 days for 
two 30-minute periods per day until 
the wound healed to stage II. There-
after, the frequency was reduced to 
64 pps (250 p..C/s), because we be-
lieved the higher pulse frequency 
might be harmful to the newly 
healed tissue. Although the healing 
rate of 14% a week after 4 weeks of 
stimulation in this study appears 
similar to the healing rates demon-
strated in other studies,u we cannot 
discern from our study what effect, 
if any, the two different pulse fre-
quencies had on the rates of healing 
or the healing process. 
Additional studies are needed to iden-
tify the mechanisms involved in the 
promotion of wound healing with 
electrical stimulation and to deter-
mine the stimulus variables that most 
efficaciously accelerate tissue repair. It 
is notewonhy that very few adverse 
effectS attributable to electrical stimu-
lation were reported during this 
study. Those that were reponed were 
minor and of little consequence. 
Conclusion 
The healing rate of 14% a week of 
chronic wounds in the treatment 
group falls within the range of 13% 
to 46% reponed in the literature. Al-
though one group received actual 
electrical stimulation and the other 
group received sham electrical stimu-
lation, the groups' treatment protocols 
were otherwise identical. We believe, 
therefore, that the differences be-
nveen the healing rates of the two 
groups can be attributed to the elec-
trical stimulation and that this study 
documents that electrical stimulation 
enhances healing of chronic ischemic 
wounds. We conclude that the use of 
electrical stimulation in the dosage 
and manner used in this study is a 
safe and effective way to treat stage II, 
III, and N chronic dermal ulcers. 
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